Transcat, Inc. (NASDAQ:TRNS) Q2 2024 Earnings Call Transcript

Transcat, Inc. (NASDAQ:TRNS) Q2 2024 Earnings Call Transcript October 31, 2023

Operator: Greetings welcome to Transcat Inc's Second Quarter Fiscal 2024 Financial Results. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to Tom Barbato, CFO. Thank you, you may begin.

Thomas Barbato: Thank you, operator, and good morning everyone. We appreciate your time and your interest in Transcat. With me here on the call today is our President and CEO, Lee Rudow; and our Chief Operating Officer, Mark Doheny. We will begin the call with some prepared remarks and then we'll open it up the call for questions. Our earnings release crossed the wire after the market closed yesterday. Both the earnings release and the slides that we will reference during our prepared remarks can be found on our website transcat.com in the investor relations section. If you would, please refer to slide two. As you are aware, we may make forward-looking statements during the formal presentation and Q&A portion of this teleconference.

These statements apply to future events, which are subject to risks and uncertainties as well as other factors that could cause the actual results to differ materially from where we are today. These factors are outlined in the news release as well as in the documents filed by the company with the SEC. You can find those on our website where we regularly post information about the company as well as on the SEC's website at sec.gov. We undertake no obligation to publicly update or correct any of the forward-looking statements contained in this call, whether as a result of new information, future events or otherwise, except as required by law. Please review our forward-looking statements in conjunction with these precautionary factors. Additionally, during today's call, we will discuss certain non-GAAP measures, which we believe will be useful in evaluating our performance.

You should not consider the presentation of this additional information in isolation or as a substitute for results prepared in accordance with GAAP. We've provided reconciliations of non-GAAP to compare GAAP measures in the tables accompanying the earnings release. With that I'll turn the call over to Lee.

Lee Rudow: Okay. Thank you, Tom. Good morning, everyone, thank you for joining us on the call today. Transcat delivered strong performance across our entire business portfolio again in the second quarter of fiscal 2024. Consolidated revenue was up 11% to $62.8 million as demand for Transcat services continued to be strong. Consolidated gross margin expanded 230 basis points to 32% as margins expanded in both our Service and Distribution segments. Adjusted EBITDA, a key metric for us given our successful acquisition strategy, grew 24% from the prior year to $9.3 million. Operating cash flow in the second quarter was $8.5 million and $16 million year-to-date. Turning to our second quarter Service segment performance. Our differentiated suite of services continued to support performance at a very high level.

We recorded our 58th straight quarter of year-over-year service revenue growth. Service revenue grew 17% including double-digit organic service growth of 10%. Recurring revenue streams and a differentiated defendable value proposition continue to foster durability and resiliency in our service growth model. And we continue to benefit from strong demand throughout multiple regulated service industries that include pharmaceutical, medical device, biomedical and as well aerospace and defense. Service gross margin was 34% in the second quarter, which represents 140 basis point increase over prior year. Margin expansion was primarily driven by leverage on double-digit organic growth, increased productivity from automation and significant process improvements throughout our network of calibration labs.

Turning to Distribution for the second quarter, gross margins expanded 340 basis points from prior year driven by growth and an increase in mix of our high-margin rental business. Both core distribution and rentals continue to drive a significant number of leads and opportunities into our Service segment, supporting consistent strong organic growth. The combination of products, rentals, along with calibration and NEXA's cost control and optimization services remains unique. We've executed well expanding our addressable markets and our value proposition has never been stronger. Overall, strong performance for Transcat in the second quarter of fiscal 2024. The 24% increase in EBITDA is due in part to our ability to achieve our revenue and cost synergy objectives on the companies we acquire.

We start by identifying and acquiring companies that are good strategic fit for Transcat, but those are only the first two steps. Whether we acquire an adjacent company to expand our markets, a geographic footprint addition, or classic bolt-on to our core calibration services, it is through integration that Transcat drives differentiation. And we are very proud of the work our team has done on this front. You could see it, you could see it in the results, the results of their work as margins and profits increase. And of course, acquisitions will continue to be an important part of our overall growth strategy. In the second quarter, we acquired Axiom Test Equipment rentals, the largest acquisition in Transcat's history, and SteriQual a life science service company specializing in commissioning, qualification and validation services.

Axiom is a great synergistic fit with Transcat's traditional rental business that was launched organically in 2015. Growth synergies between Axiom and Transcat's traditional rental business include go-to-market selling and market -- go-to-market selling and marketing strategies with complementary inventories and customer base. We expect the combined rental business to perform well, as we capitalize on what we consider a one plus one equals three opportunity. SteriQual expands our addressable market within the NEXA cost control and optimization space. SteriQual also fortifies NEXA's differentiated single-source solutions model NF3. In addition to the two acquisitions in the second quarter of fiscal 2024, perhaps what stands out most is the completion of a public offering of our common stock, which was used to repay our credit facility.

An engineer overseeing the calibrations of a sophisticated flow meter.

The highly successful offering displayed robust demand for Transcat stock among institutional investors who recognize, understand and value our long-term demonstrated track record of profitable revenue growth, expansion of addressable markets and sustainable margin improvement. And with that, I'll turn things over to Tom for a more detailed view of our fiscal 2023 second quarter results.

Thomas Barbato: Thanks, Lee. I'll start on slide four of the earnings deck posted on our website, which provides detail regarding our revenue on a consolidated basis and by segment for the second quarter of fiscal 2024. Second quarter consolidated revenue of $62.8 million was up 11% versus prior year on Service segment's strength and slight growth in our Distribution business. Looking at it by segment, Service segment revenue growth remained very strong at 17% with 10% of the growth coming organically, and the other 7% from acquisition. As Lee mentioned, we continue to see high levels of demand in our Services business. Turning to Distribution, revenue of $21.4 million grew 1% from the prior year. We continue to see growth in the higher-margin rental business, which also benefited from the Axiom Test Equipment acquisition, which closed in mid second quarter.

Turning to slide five, our consolidated gross profit for the first quarter of $20.1 million was up 20% from the prior year. And our gross margin expanded 230 basis points in the second quarter. Service gross margin expanded 140 basis points. The service margin increase further demonstrates our ability to benefit from the inherent leverage in our operating model as well as higher levels of technician productivity, supported by continuous improvement initiatives like automation and process streamlining within our networks of labs. Distribution segment gross margin of 28.3% was up 340 basis points from the prior year, driven by a larger mix of higher margin rental revenue. Turning to slide six. Q2 net income of $0.5 million decreased from the prior year due to a non-recurring, non-cash charge of $2.8 million for the previously disclosed amended NEXA earn-out.

The NEXA earn-out agreement was amended to recognize the expanded scope of the NEXA portfolio, which includes the acquisition of SteriQual, and this change is based on current expectations of future business performance. Diluted earnings per share came in at $0.06, the one-time earn out charge reduced earnings per share by $0.35. We report adjusted diluted earnings per share as well to normalize for the impacts of upfront and ongoing acquisition related costs. Q2 adjusted diluted earnings per share of $0.60 increased $0.16 or 36% from the prior year. A reconciliation of adjusted diluted earnings per share to diluted earnings per share can be found in the supplemental section of this presentation. Flipping to slide seven where we show our adjusted EBITDA and adjusted EBITDA margin.

We use adjusted EBITDA, which is non-GAAP to gauge the performance of our business because we believe it is the best measure of our operating performance and ability to generate cash. As we continue to execute on our acquisition strategy, this metric becomes even more important to highlight as it does adjust for one-time deal-related transactions cost as well as the increased level of non-cash expense that will hit our income statement from acquisition purchase accounting. With that in mind, second quarter consolidated adjusted EBITDA of $9.3 million was up 24% from the same quarter in the prior year. And adjusted EBITDA margin expanded 160 basis points. Both segments had adjusted EBITDA growth compared to last year. As always, a reconciliation of adjusted EBITDA to operating income and net income can be found in the supplemental section of this presentation.

Moving to slide eight, operating free cash flow significantly improved up $10 million versus the prior year. We've generated $16 million in operating cash flow in the first half of the fiscal year. Q2 capital expenditures were $600,000 higher than prior year and continued to be centered around Service segment capabilities, technology, including automation, and future growth projects. Slide nine highlights our strong balance sheet. At the end of the quarter, we had a total net debt of $52 million with a leverage ratio of 1.37x, and $32 million available from our credit facility. Subsequent to the end of the quarter the revolving credit facility was paid off using the funds from the secondary offering, which closed early in the third quarter.

Lastly, we expect to file our 10-Q on November 1st. And with that, I'll turn it back to you, Lee.

Lee Rudow: Thanks, Tom. Transcat has consistently delivered exceptional results throughout the past decade and through various economic cycles. We expect profitable growth and sustainable margin improvement to continue as we increase shareholder value. We expect our successful and unique acquisition strategy to drive synergistic growth opportunities and expand our addressable markets. We expect to leverage continuous process improvement and automation including robotics, which we're in the very early stages of developing as key enablers to future margin expansion. In other words, we expect to get bigger and we expect to get better. That's the Transcat way. As we work our way through the third quarter of fiscal 2024, we are still expecting high single-digit to low double-digit organic service growth for the full fiscal year.

And we expect gross margin expansion as well. Perhaps most importantly, we expect to develop, recruit, and retain superior management and leadership throughout our organization. It's the people of Transcat that continue to move the needle and push the company to new heights. We expect to continue that as we journey into the future. And with that, operator, please open the line for questions.

See also Billionaire Marc Lasry's Top 10 Stock Picks and 35 Good Tinder Bios for Gym Guys.

To continue reading the Q&A session, please click here.